Hollister and Heavy Grass Collaborate with Slipknot Co-Founder Shawn "Clown" Crahan on New HashBone Line Psychedelics Investing
DEADLINE TODAY: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
BLU Final Deadline Today: Rosen, Trusted Investor Counsel, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
Abbott Receives CE Mark for Navitor, the Latest-Generation Transcatheter Aortic Valve Implantation System to Treat Aortic Stenosis Medical Device Investing
Gabrielle Union-Wade Joins 'Don't Skip' Campaign to Encourage Doctor Well-Visits and Recommended Vaccinations Pharmaceutical Investing
Seelos Therapeutics Announces Positive Topline Data from the Open-Label Study of SLS-002 , Demonstrating a Significant Treatment Effect and a Well Tolerated Safety Profile for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Psychedelics Investing
FINAL DEADLINE NOTICE FROM FIRM THAT FILED CASE: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
BLU FINAL DEADLINE TOMORROW: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
